|
Market Closed -
Sao Paulo
01:20:32 17/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 78.56 BRL | -2.65% |
|
+5.78% | +19.10% |
| 16/10 | EU Medicines Agency Panel Backs CuraTeQ Biologics' Neupogen Biosimilar for Neutropenia | MT |
| 15/10 | Goldman Sachs Adjusts Price Target on Amgen to $481 From $475 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -2.65% | +5.78% | +19.10% | +36.15% | +94.02% | 23TCr |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMGN34 Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
